These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8899319)

  • 41. Mitogenic properties of Ukrain (NSC-6315170) on human peripheral blood monocytes: clinical implications.
    Jin YM; Nowicky JW; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):99-101. PubMed ID: 8899311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chelidonium majus L. (Ukrain) in the treatment of cancer patients.
    Lohninger A; Hamler F
    Drugs Exp Clin Res; 1992; 18 Suppl():73-7. PubMed ID: 1305049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
    Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
    Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical studies of Ukrain in terminal cancer patients (phase II).
    Musianowycz J; Judmajer F; Manfreda D; Spängler P; Albrecht H; Hoffmann J; Meijer D
    Drugs Exp Clin Res; 1992; 18 Suppl():45-50. PubMed ID: 1305043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ukrain treatment in a patient with stage IV neuroblastoma. A case report.
    Aschhoff B
    Drugs Exp Clin Res; 1998; 24(5-6):243-5. PubMed ID: 10190082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice.
    Poteryaeva ON; Falameyeva OV; Korolenko TA; Kaledin VI; Djanayeva SJ; Nowicky JW; Sandula J
    Drugs Exp Clin Res; 2000; 26(5-6):301-6. PubMed ID: 11345042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
    Boyko VN; Zholus RB
    Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours.
    Danilos J; Zbroja-Sontag W; Baran E; Kurylcio L; Kondratowicz L; Jusiak L
    Drugs Exp Clin Res; 1992; 18 Suppl():55-62. PubMed ID: 1305046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of Ukrain on human xenografts in vitro.
    Nowicky JW; Hiesmayr W; Nowicky W; Liepins A
    Drugs Exp Clin Res; 1996; 22(3-5):93-7. PubMed ID: 8899310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of Ukrain on the redox processes of hepatocytes.
    Zhalilo LI; Susak YM; Zemskov SV; Susak IA
    Drugs Exp Clin Res; 1996; 22(3-5):189-91. PubMed ID: 8899328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570).
    Liepins A; Nowicky JW; Bustamante JO; Lam E
    Drugs Exp Clin Res; 1996; 22(3-5):73-9. PubMed ID: 8899308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones.
    Jagiello-Wójtowicz E; Kleinrok Z; Feldo M; Chodkowska A; Szklarczyk V; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):305-8. PubMed ID: 10190092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):257-9. PubMed ID: 11345035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ukrain treatment of rhabdomyosarcoma (case report).
    Kotsay B; Lisnyak O; Myndiuk O; Romanys-hyn J; Fabri O
    Drugs Exp Clin Res; 1996; 22(3-5):239-41. PubMed ID: 8899339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ukrain treatment of a patient with retroperitoneal synovial sarcoma. Case report.
    Prokopchuk OL; Zemskov SV; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):255-6. PubMed ID: 11345034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ukrain - a new cancer cure? A systematic review of randomised clinical trials.
    Ernst E; Schmidt K
    BMC Cancer; 2005 Jul; 5():69. PubMed ID: 15992405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical testing of Ukrain.
    Nowicky W
    Lancet Oncol; 2001 Jan; 2(1):10. PubMed ID: 11905612
    [No Abstract]   [Full Text] [Related]  

  • 58. Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report).
    Lohninger A; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):259-62. PubMed ID: 8899343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ukrain: a novel antitumor drug.
    Uglyanitsa KN; Nefyodov LI; Doroshenko YM; Nowicky JW; Volchek IV; Brzosko WJ; Hodysh YJ
    Drugs Exp Clin Res; 2000; 26(5-6):341-56. PubMed ID: 11345050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters.
    Jagiello-Wójtowicz E; Kleinrok Z; Feldo M; Chodkowska A; Szponar J; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):295-9. PubMed ID: 10190090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.